Opinion and evidence in cardiovascular therapeutics

被引：0
|
作者：
不详
机构：
来源：
American Journal of Cardiovascular Drugs | 2002年 / 2卷 / 6期
关键词：
Losartan; Amlodipine; Implantable Cardioverter Defibrillator; Valsartan; Alteplase;
D O I：
10.2165/00129784-200202060-00007
中图分类号：
学科分类号：
摘要：
Cardiovascular therapeutics is a vast and evolving area for researchers, primary care physicians and specialists. To help keep you up-to-date with the latest advances worldwide on all aspects of drug therapy and management of cardiovascular disorders, this section of the journal brings you information selected from the drug therapy reporting service Inpharma Weekly1. The following reports are selected from the latest issues, summarizing the most important research and development news, clinical studies, treatment guidelines, pharmacoeconomic and adverse reaction news, and expert opinion pieces published across a broad range of literature sources.
引用
收藏
页码：433 / 443
页数：10
相关论文
共 50 条
  • [41] Opinion: miRNAs - The new wave of molecular cancer therapeutics
    Lopez-Bertoni, Hernando
    Laterra, John
    TRANSLATIONAL ONCOLOGY, 2021, 14 (06):
  • [42] Editorial: Highlights for Cardiovascular Therapeutics in 2021 - Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
    Yang, William Y.
    Nguyen, Bonnie
    Wu, Sheng
    Yu, Jun
    Wang, Hong
    Yang, Xiaofeng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [43] A matter of opinion or evidence!
    Wright, Dave
    Bradbury, Ian
    Cuckle, Howard
    Gardosi, Jason
    Tonks, Ann
    Standing, Sue
    Benn, Peter
    PRENATAL DIAGNOSIS, 2006, 26 (12) : 1184 - 1184
  • [44] Opinion versus evidence
    Carlsson, GE
    INTERNATIONAL JOURNAL OF PROSTHODONTICS, 1997, 10 (06) : 497 - 497
  • [45] Opinion Evidence in Illinois
    Landon, P. A.
    LAW QUARTERLY REVIEW, 1944, 60 (238): : 201 - 202
  • [46] Cardiovascular risk and rheumatoid arthritis:: clinical practice guidelines based on published evidence and expert opinion
    Pham, Thao
    Gossec, Laure
    Constantin, Arnaud
    Pavy, Stephan
    Bruckert, Eric
    Cantagrel, Alain
    Combe, Bernard
    Flipo, Rene-Marc
    Goupille, Philippe
    Le Loet, Xavier
    Mariette, Xavier
    Puechal, Xavier
    Schaeverbeke, Thierry
    Sibilia, Jean
    Tebib, Jacques
    Wendling, Daniel
    Dougados, Maxime
    JOINT BONE SPINE, 2006, 73 (04) : 379 - 387
  • [47] Common cardiovascular medications in cancer therapeutics
    Vaklavas, Christos
    Chatzizisis, Yiannis S.
    Tsimberidou, Apostolia Maria
    PHARMACOLOGY & THERAPEUTICS, 2011, 130 (02) : 177 - 190
  • [48] HDL and microRNA therapeutics in cardiovascular disease
    Michell, Danielle L.
    Vickers, Kasey C.
    PHARMACOLOGY & THERAPEUTICS, 2016, 168 : 43 - 52
  • [49] Evaluating the economic implications of cardiovascular therapeutics
    Califf, RM
    AMERICAN HEART JOURNAL, 1999, 137 (05) : S35 - S37
  • [50] microRNA Therapeutics in Cardiovascular Disease Models
    Dangwal, Seema
    Thum, Thomas
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 : 185 - 203
12345